Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane in Subjective Tinnitus (EASE)
NCT00739635Phase 3Completed
- Sponsor
- Merz
- Start
- Sep 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in tinnitus comparing Neramexane with Placebo (2 arms). Primary endpoint: Tinnitus-Beeinträchtigungs-Fragebogen-12 Total Score Change at 17 weeks. Started Sep 2008; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT00739635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739635.